Author response for "Identification of <scp> <i>ENPP1</i> </scp> haploinsufficiency in patients with diffuse idiopathic skeletal hyperostosis and early‐onset osteoporosis"
Hajime Kato, Nobuaki Ito(University of Tokyo Hospital), Masaomi Nangaku(The University of Tokyo), Ethan R. Lester(Yale University), Toshinari Takamura(Kanazawa University), Hideki Yamaguchi, Anenya J. Ansh(Yale University), Demetrios T. Braddock(Yale University), Yo Niida(Kanazawa University), Yoshitomo Hoshino(University of Tokyo Hospital), Yuka Kinoshita(University of Tokyo Hospital), Naoko Hidaka(University of Tokyo Hospital), Noriko Makita(University of Occupational and Environmental Health Japan), Masamitsu Nakazato(University of Miyazaki), Yuki Taniguchi, Taku Saito(The University of Tokyo), Minae Koga(University of Tokyo Hospital), Taisuke Uchida(Kyushu University)
Cited by 0
Related Papers
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Excessive mechanical loading promotes osteoarthritis through the gremlin-1–NF-κB pathway
|Nature Communications|2019|289
Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period
|Calcified Tissue International|2019|160
Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference
|Kidney International|2017|149
X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment
|Endocrine Reviews|2018|148